Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records
Main Authors: | Kamel Mohammedi, Audrey Cordon, Vincent Rigalleau, Ninon Foussard, Céline Bairras-Martin, Thierry Couffinhal, Julien Bezin, Antoine Benard |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Cardiovascular Diabetology |
Online Access: | https://doi.org/10.1186/s12933-023-02069-y |
Similar Items
-
Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design
by: Kamel Mohammedi, et al.
Published: (2021-03-01) -
Comment on Peker, T.; Boyraz, B. The Relationship between Resistant Hypertension and Advanced Glycation End-Product Levels Measured Using the Skin Autofluorescence Method: A Case–Control Study. <i>J. Clin. Med.</i> 2023, <i>12</i>, 6606
by: Fadi Alkhami, et al.
Published: (2023-12-01) -
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures
by: Fadi Alkhami, et al.
Published: (2024-01-01) -
Skin autofluorescence predicts cancer in subjects with type 2 diabetes
by: Laurence Baillet-Blanco, et al.
Published: (2021-08-01) -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis
by: Clément Mathieu, et al.
Published: (2023-05-01)